Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
Clinical trial NCT02949258 · UNKNOWN
Trial details
- NCT number
- NCT02949258
- Sponsor
- Jinling Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2019-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.